These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 15948030)
21. Enhanced absorption and tissue distribution of paclitaxel following oral administration of DHP 107, a novel mucoadhesive lipid dosage form. Shin BS; Kim HJ; Hong SH; Lee JB; Hwang SW; Lee MH; Yoo SD Cancer Chemother Pharmacol; 2009 Jun; 64(1):87-94. PubMed ID: 18941747 [TBL] [Abstract][Full Text] [Related]
22. Cremophor-free intravenous microemulsions for paclitaxel II. Stability, in vitro release and pharmacokinetics. Nornoo AO; Chow DS Int J Pharm; 2008 Feb; 349(1-2):117-23. PubMed ID: 17869458 [TBL] [Abstract][Full Text] [Related]
23. [Preparation of paclitaxel-loaded chitosan polymeric micelles and influence of surface charges on their tissue biodistribution in mice]. Huo MR; Zhou JP; Wei Y; Lü L Yao Xue Xue Bao; 2006 Sep; 41(9):867-72. PubMed ID: 17111835 [TBL] [Abstract][Full Text] [Related]
24. Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Liang HF; Chen CT; Chen SC; Kulkarni AR; Chiu YL; Chen MC; Sung HW Biomaterials; 2006 Mar; 27(9):2051-9. PubMed ID: 16307794 [TBL] [Abstract][Full Text] [Related]
25. Pharmacologic sensitivity of paclitaxel to its delivery vehicles drives distinct clinical outcomes of paclitaxel formulations. Li Y; Chen N; Palmisano M; Zhou S Mol Pharm; 2015 Apr; 12(4):1308-17. PubMed ID: 25714793 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and tissue distribution of PGG-paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenografts. Wang X; Zhao G; Van S; Jiang N; Yu L; Vera D; Howell SB Cancer Chemother Pharmacol; 2010 Feb; 65(3):515-26. PubMed ID: 19593566 [TBL] [Abstract][Full Text] [Related]
27. [Comparative study on pharmacokinetics and tissue distribution of a novel microemulsion based on the paclitaxel/L-OH lipid complex and paclitaxel injection in cremophor]. Ma YL; Ye J; Zhang PX; Xia XJ; Liu YL Yao Xue Xue Bao; 2013 Nov; 48(11):1698-704. PubMed ID: 24475708 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of carbon nanoparticle-paclitaxel suspension for use in intraperitoneal chemotherapy. Cai Y; Zhang X Hepatogastroenterology; 2013; 60(128):1998-2003. PubMed ID: 24719940 [TBL] [Abstract][Full Text] [Related]
29. Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol). Wu L; Tang C; Yin C Drug Dev Ind Pharm; 2010 Apr; 36(4):439-48. PubMed ID: 19824865 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and biodistribution of paclitaxel-loaded microspheres. Yan F; Tang S; Fu Q Arzneimittelforschung; 2012 Apr; 62(4):176-80. PubMed ID: 22270845 [TBL] [Abstract][Full Text] [Related]
31. Paclitaxel and its formulations. Singla AK; Garg A; Aggarwal D Int J Pharm; 2002 Mar; 235(1-2):179-92. PubMed ID: 11879753 [TBL] [Abstract][Full Text] [Related]
32. Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. Mo Y; Lim LY J Control Release; 2005 Nov; 108(2-3):244-62. PubMed ID: 16213056 [TBL] [Abstract][Full Text] [Related]
33. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy. Yoshizawa Y; Kono Y; Ogawara K; Kimura T; Higaki K Int J Pharm; 2011 Jun; 412(1-2):132-41. PubMed ID: 21507344 [TBL] [Abstract][Full Text] [Related]
34. Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel. Wang C; Wang Y; Wang Y; Fan M; Luo F; Qian Z Int J Pharm; 2011 Jul; 414(1-2):251-9. PubMed ID: 21596124 [TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of polymeric pH-sensitive STEALTH® nanoparticles for tumor delivery of a lipophilic prodrug of paclitaxel. Lundberg BB Int J Pharm; 2011 Apr; 408(1-2):208-12. PubMed ID: 21296135 [TBL] [Abstract][Full Text] [Related]
36. Selective tissue distribution and long circulation endowed by paclitaxel loaded PEGylated poly(ε-caprolactone-co-L-lactide) micelles leading to improved anti-tumor effects and low systematic toxicity. Wang F; Shen Y; Xu X; Lv L; Li Y; Liu J; Li M; Guo A; Guo S; Jin F Int J Pharm; 2013 Nov; 456(1):101-12. PubMed ID: 23968782 [TBL] [Abstract][Full Text] [Related]
37. Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution. Saravanakumar G; Min KH; Min DS; Kim AY; Lee CM; Cho YW; Lee SC; Kim K; Jeong SY; Park K; Park JH; Kwon IC J Control Release; 2009 Dec; 140(3):210-7. PubMed ID: 19560497 [TBL] [Abstract][Full Text] [Related]
38. P450 induction alters paclitaxel pharmacokinetics and tissue distribution with multiple dosing. Gustafson DL; Long ME; Bradshaw EL; Merz AL; Kerzic PJ Cancer Chemother Pharmacol; 2005 Sep; 56(3):248-54. PubMed ID: 15856231 [TBL] [Abstract][Full Text] [Related]
39. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice. Dalela M; Shrivastav TG; Kharbanda S; Singh H ACS Appl Mater Interfaces; 2015 Dec; 7(48):26530-48. PubMed ID: 26528585 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics, tissue distribution and anti-tumour efficacy of paclitaxel delivered by polyvinylpyrrolidone solid dispersion. Liu X; Sun J; Chen X; Wang S; Scott H; Zhang X; Zhang Q J Pharm Pharmacol; 2012 Jun; 64(6):775-82. PubMed ID: 22571255 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]